BFS
CVS icon

Bradley Foster & Sargent’s CVS Health CVS Stock Holding History

Bradley Foster & Sargent’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97M Sell
28,685
-207
-0.7% -$18.5K 0.04% 197
2026
Q1 		$2.08M Sell
28,892
-786
-3% -$60.5K 0.03% 219
2025
Q4 		$2.36M Sell
29,678
-66
-0.2% -$5.2K 0.03% 202
2025
Q3 		$2.24M Sell
29,744
-288
-1% -$19.7K 0.03% 208
2025
Q2 		$2.07M Buy
30,032
+7,568
+34% +$496K 0.03% 215
2025
Q1 		$1.52M Buy
22,464
+88
+0.4% +$5.27K 0.03% 225
2024
Q4 		$1M Sell
22,376
-1,850
-8% -$104K 0.02% 278
2024
Q3 		$1.52M Sell
24,226
-1,614
-6% -$94.2K 0.03% 236
2024
Q2 		$1.53M Sell
25,840
-19,576
-43% -$1.22M 0.03% 223
2024
Q1 		$3.62M Sell
45,416
-900
-2% -$68.7K 0.07% 165
2023
Q4 		$3.66M Sell
46,316
-11,708
-20% -$833K 0.07% 164
2023
Q3 		$4.01M Hold
58,024
– – 0.08% 154
2023
Q2 		$4.01M Buy
58,024
+516
+0.9% +$36.7K 0.08% 154
2023
Q1 		$4.27M Sell
57,508
-1,544
-3% -$129K 0.1% 136
2022
Q4 		$5.5M Sell
59,052
-305
-0.5% -$29.4K 0.14% 114
2022
Q3 		$5.66M Buy
59,357
+726
+1% +$71.9K 0.16% 102
2022
Q2 		$5.43M Buy
58,631
+1,411
+2% +$138K 0.14% 110
2022
Q1 		$5.79M Buy
57,220
+10,089
+21% +$1.06M 0.12% 128
2021
Q4 		$4.86M Buy
47,131
+3,917
+9% +$362K 0.1% 131
2021
Q3 		$3.67M Sell
43,214
-1,346
-3% -$113K 0.09% 140
2021
Q2 		$3.72M Sell
44,560
-209
-0.5% -$17.1K 0.09% 143
2021
Q1 		$3.37M Buy
44,769
+1,817
+4% +$132K 0.09% 146
2020
Q4 		$2.93M Sell
42,952
-2,569
-6% -$167K 0.08% 151
2020
Q3 		$2.66M Buy
+45,521
New +$2.83M 0.08% 144
2020
Q1 		$2.23M Buy
37,535
+498
+1% +$33.2K 0.09% 135
2019
Q4 		$2.75M Buy
37,037
+927
+3% +$65.1K 0.08% 146
2019
Q3 		$2.28M Sell
36,110
-102
-0.3% -$6.04K 0.08% 151
2019
Q2 		$1.97M Sell
36,212
-1,960
-5% -$106K 0.07% 163
2019
Q1 		$2.06M Sell
38,172
-7,065
-16% -$436K 0.07% 162
2018
Q4 		$2.96M Buy
45,237
+16,226
+56% +$1.21M 0.12% 132
2018
Q3 		$2.28M Buy
29,011
+34
+0.1% +$2.43K 0.08% 164
2018
Q2 		$1.86M Buy
28,977
+2,500
+9% +$165K 0.07% 175
2018
Q1 		$1.65M Buy
26,477
+765
+3% +$54.9K 0.06% 179
2017
Q4 		$1.86M Sell
25,712
-3,701
-13% -$269K 0.07% 167
2017
Q3 		$2.39M Buy
29,413
+4,462
+18% +$353K 0.09% 149
2017
Q2 		$2.01M Sell
24,951
-1,278
-5% -$101K 0.08% 158
2017
Q1 		$2.06M Sell
26,229
-17
-0.1% -$1.36K 0.08% 154
2016
Q4 		$2.07M Sell
26,246
-6,018
-19% -$487K 0.09% 150
2016
Q3 		$2.87M Sell
32,264
-196,877
-86% -$18.6M 0.13% 120
2016
Q2 		$21.9M Buy
229,141
+970
+0.4% +$96.7K 0.98% 34
2016
Q1 		$23.7M Buy
228,171
+12,932
+6% +$1.26M 1.1% 28
2015
Q4 		$21M Buy
215,239
+16,315
+8% +$1.6M 0.96% 35
2015
Q3 		$19.2M Buy
198,924
+56,882
+40% +$5.98M 0.95% 32
2015
Q2 		$14.9M Buy
142,042
+14,609
+11% +$1.49M 0.68% 52
2015
Q1 		$13.2M Buy
127,433
+62,027
+95% +$6.28M 0.6% 60
2014
Q4 		$6.3M Buy
65,406
+4,413
+7% +$389K 0.3% 88
2014
Q3 		$4.85M Buy
60,993
+17,942
+42% +$1.41M 0.23% 103
2014
Q2 		$3.25M Buy
43,051
+1,720
+4% +$130K 0.16% 124
2014
Q1 		$3.09M Buy
41,331
+21,818
+112% +$1.54M 0.16% 121
2013
Q4 		$1.4M Buy
19,513
+926
+5% +$59.5K 0.07% 167
2013
Q3 		$1.05M Buy
18,587
+857
+5% +$51.1K 0.06% 174
2013
Q2 		$1.01M Buy
+17,730
New +$1.03M 0.06% 171

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bradley Foster & Sargent's CVS Position: Q2 2026 in Review

Bradley Foster & Sargent reduced its CVS Health (CVS) stake by 0.72% in Q2 2026, selling an estimated $18.5K and leaving 28,685 shares worth $2.97M. The position accounts for 0.04% of the portfolio, ranked #197.

Bradley Foster & Sargent first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.7M in Q1 2016. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Bradley Foster & Sargent held 28,685 shares of CVS Health worth $2.97M as of Q2 2026.
  • Bradley Foster & Sargent sold 207 CVS Health shares in Q2 2026, an estimated $18.5K.
  • CVS Health made up 0.04% of Bradley Foster & Sargent's portfolio in Q2 2026, its #197 holding.
  • Bradley Foster & Sargent first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Bradley Foster & Sargent's CVS Health position peaked at $23.7M in Q1 2016.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.